These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4868475)

  • 1. Chlorphentermine as an anorexigenic agent in adolescent obesity. Report of its efficacy in a double-blind study of 30 teen-agers.
    Rauh JL; Lipp R
    Clin Pediatr (Phila); 1968 Mar; 7(3):138-40. PubMed ID: 4868475
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity-depression: clinical evaluation with a new anorexigenic agent.
    Kornhaber A
    Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 5. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
    Elliott BW
    Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
    De Felice EA; Bronstein S; Cohen A
    Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
    [No Abstract]   [Full Text] [Related]  

  • 7. [L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
    González Barranco J; Rull JA; Lozano Castañeda O
    Prensa Med Mex; 1974; 39(5-6):298-9. PubMed ID: 4612507
    [No Abstract]   [Full Text] [Related]  

  • 8. Diethylpropion hydrochloride: an effective appetite suppressant.
    Bolding OT
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminorex fumarate: a double-blind trial and examination for signs of pulmonary arterial hypertension.
    Kew MC
    S Afr Med J; 1970 Apr; 44(14):421-3. PubMed ID: 4910309
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled clinical evaluation of a new anorectic agent in obese adults.
    Elmaleh MK; Miller J
    Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
    Feldman HS
    J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of the anorexic activity and safety of 42-548 in children. Report of a clinical trial.
    Sharma RK; Collipp PJ; Rezvani I; Strimas J; Maddaiah VT; Rezvani E
    Clin Pediatr (Phila); 1973 Mar; 12(3):145-9. PubMed ID: 4573674
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 14. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a new anorexic agent in adolescence.
    Bauta HP
    Conn Med; 1974 Sep; 38(9):460-3. PubMed ID: 4606529
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change.
    Sletten IW; Sundland D; Pichardo J; Viamontes G
    Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 18. A double blind controlled trial of a new anorectic agent AN448.
    Woodhouse SP; Nye ER; Anderson K; Rawlings J
    N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.
    Waal-Manning HJ; Simpson FO
    Lancet; 1969 Dec; 2(7635):1392-5. PubMed ID: 4188278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effect of various appetite depressants under controlled conditions].
    Kreze A; Toman A
    Bratisl Lek Listy; 1973; 59(4):406-12. PubMed ID: 4751882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.